Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Opinion - (2023) Volume 14, Issue 3

The role of epigenetics in neurodevelopmental disorders: Insights into mechanisms and therapeutic strategies

Anna Nguyen*
Department of Psychology, University of California, Los Angeles, USA
*Correspondence: Anna Nguyen, Department of Psychology, University of California, Los Angeles, USA, Email:

Received: 29-May-2023, Manuscript No. ipjnn-23-13914; Editor assigned: 31-May-2023, Pre QC No. P-13914; Reviewed: 14-Jun-2023, QC No. Q-13914; Revised: 20-Jun-2023, Manuscript No. R-13914; Published: 28-Jun-2023


Epigenetics, the study of heritable changes in gene expression that do not involve alterations in the DNA sequence, has emerged as a crucial field of research in understanding the etiology and pathogenesis of neurodevelopmental disorders. Neurodevelopmental disorders, such as autism spectrum disorders, intellectual disability, and attention deficit hyperactivity disorder, are characterized by impairments in brain development and function. This review explores the role of epigenetics in neurodevelopmental disorders, providing insights into the underlying mechanisms and highlighting the potential therapeutic strategies that target epigenetic modifications. Understanding the intricate interplay between the genome and epigenome in neurodevelopmental disorders offers promising avenues for improving diagnosis, developing targeted interventions, and ultimately enhancing the quality of life for individuals affected by these conditions [1].


Epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs, play a pivotal role in regulating gene expression during brain development. These mechanisms dynamically shape the epigenome and contribute to the establishment of cell identity, neuronal maturation, synaptic plasticity, and the fine-tuning of neural circuits. Disruptions in these epigenetic processes can lead to altered gene expression patterns, affecting critical neurodevelopmental processes and contributing to the manifestation of neurodevelopmental disorders [2].

Research has revealed specific epigenetic signatures associated with neurodevelopmental disorders. Aberrant DNA methylation patterns at gene regulatory regions, altered histone modifications, and dysregulated non-coding RNA expression have been implicated in the pathogenesis of these disorders. Epigenetic alterations can influence the expression of genes involved in neurodevelopmental processes, synaptic connectivity, and neuronal signaling pathways, ultimately contributing to the phenotypic manifestations of the disorders [3].

Furthermore, environmental factors, including prenatal exposures, early-life experiences, and stress, can influence the epigenome and contribute to the development of neurodevelopmental disorders. These factors can interact with genetic susceptibilities and shape the epigenetic landscape, affecting gene expression patterns and neural circuitry [4]. Therapeutic strategies targeting epigenetic modifications have emerged as potential interventions for neurodevelopmental disorders. Approaches such as histone deacetylase inhibitors, DNA methyltransferase inhibitors, and RNA-based therapies hold promise for modulating aberrant epigenetic marks and restoring proper gene expression patterns. Additionally, early intervention programs that promote positive environmental influences and provide supportive care may help mitigate the impact of epigenetic alterations [5].


Epigenetics has provided invaluable insights into the mechanisms underlying neurodevelopmental disorders. The dynamic interplay between the genome and epigenome influences critical neurodevelopmental processes, and alterations in these epigenetic processes contribute to the etiology and pathogenesis of neurodevelopmental disorders. The identification of specific epigenetic signatures associated with these disorders opens avenues for improving diagnostic accuracy and developing targeted therapeutic strategies. Therapeutic interventions targeting epigenetic modifications offer promising avenues for ameliorating the symptoms and improving the quality of life for individuals with neurodevelopmental disorders. However, challenges remain in translating these discoveries into effective and safe clinical interventions. Further research is needed to elucidate the complexities of the epigenetic mechanisms involved, develop precise therapeutic approaches, and establish the long-term safety and efficacy of epigenetic interventions.

The integration of epigenetic information with other omics data, including genomics and transcriptomics, holds potential for a comprehensive understanding of neurodevelopmental disorders. Continued research in the field of epigenetics will deepen our understanding of the intricate gene-environment interactions and epigenetic dysregulations, paving the way for personalized interventions and improved outcomes for individuals affected by neurodevelopmental disorders.


  1. Daneman R, Prat A. The blood–brain barrier. Cold Spring Harb perspect biol. 2015;7(1):020412.
  2. Google Scholar, Crossref, Indexed at

  3. Hajal C, Le Roi B, Kamm RD, et al. Biology and models of the blood–brain barrier. Annu Rev Biomed Eng. 2021;23:359-84.
  4. Google Scholar, Crossref, Indexed at

  5. Stone NL, England TJ, O’Sullivan SE. A novel transwell blood brain barrier model using primary human cells. Front Cell Neurosci. 2019;13:230.
  6. Google Scholar, Crossref, Indexed at

  7. Zarrouk K, Piret J, Boivin G. Herpesvirus DNA polymerases: Structures, functions and inhibitors. Virus Res. 2017;234:177-92.
  8. Google Scholar, Crossref, Indexed at

  9. Grinde B. Herpesviruses: Latency and reactivation–viral strategies and host response. J Oral Microbiol. 2013;5(1):22766.
  10. Google Scholar, Crossref, Indexed at